Economic Impact of Candida Colonization and Candida Infection in the Critically Ill Patient
- 1 April 2004
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 23 (4) , 323-330
- https://doi.org/10.1007/s10096-004-1104-x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- A Prospective and Retrospective Analysis of the Nephrotoxicity and Efficacy of Lipid‐Based Amphotericin B FormulationsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2001
- Managing the cost of care: a predictive study to identify critical care patients at risk for nosocomial pneumonia.2000
- The Impact of Surgical-Site Infections in the 1990s: Attributable Mortality, Excess Length of Hospitalization, And Extra CostsInfection Control & Hospital Epidemiology, 1999
- The Impact of Candidemia on Length of Hospital Stay, Outcome, and Overall Cost of IllnessClinical Infectious Diseases, 1998
- Risk Factors and Outcome of Nosocomial Infections: Results of a Matched Case-control Study of ICU PatientsAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patientsIntensive Care Medicine, 1997
- Selected Aspects of the Socioeconomic Impact of Nosocomial Infections: Morbidity, Mortality, Cost, and PreventionInfection Control & Hospital Epidemiology, 1996
- Nosocomial infection in surgery wards: A controlled study of increased duration of hospital stays and direct cost of hospitalizationEuropean Journal of Epidemiology, 1993
- Hospital-acquired candidemia. The attributable mortality and excess length of stayArchives of internal medicine (1960), 1988
- Cost of nosocomial infection: Relative contributions of laboratory, antibiotic, and per diem costs in serious Staphylococcus aureus infectionsAmerican Journal of Infection Control, 1988